Swiss drug firm silent on reasons to ditch medicinal plant deal

Swiss drug maker Norvatis International AB has refused to explain why it ditched the contract to buy a major ingredient for its malaria drug from Kenya-based Botanical Extracts EPZ Limited. The Kenyan firm was a major buyer of the medicinal Artemisia annua plant grown by local farmers in northern Tanzania from which the ingredients for the drug are obtained.

Source: Tanzanian News